Significance: Supplementation with low-dose sustained release arginine alleviates postprandial endothelial dysfunction in healthy hypertriglyceridemic waist adults when the baseline plasma arginine concentration is relatively low.
The association between dietary intake of α-linolenic acid (ALA), adipose tissue content of ALA, and risk of incident myocardial infarction (MI) were investigated in 57,053 participants, aged 50-64 y, who were enrolled in the prospective Danish cohort study Diet, Cancer and Health between 1993 and 1997 . The adipose tissue content of ALA was determined in all incident MI cases and in a random sex-stratified sample of the total cohort (n = 3500). During a median of 17 y of follow-up, 2177 male and 912 female cases of MI were identified. After appropriate exclusions, 2124 men and 854 women were included for analyses of dietary intake of ALA, whereas 1994 men and 770 women were included in the analysis of the adipose tissue content of ALA. In multivariate analyses (adjusting for established CHD risk factors), weak positive associations in men and weak U-shaped associations in women were shown between both dietary intake and the adipose tissue content of ALA and risk of MI, but these associations were not statistically significant. Additional adjustments for dietary factors did not influence the observed associations numerically.
Dietary Epicatechin Intake and 25-y Risk of Cardiovascular Mortality:
The Zutphen Elderly Study J.I. Dower, J.M. Geleijnse, P.C.H. Hollman, S.S. Soedamah-Muthu, D. Kromhout American Journal of Clinical Nutrition, Vol. 104, No. 1; pp. 58-64 doi: 10.3945/ajcn.115.128819 Link to full text: Click here Significance: Epicatechin intake is inversely related to coronary heart disease mortality in elderly men and to cardiovascular disease (CVD) mortality in prevalent cases of CVD.
The associations of dietary epicatechin intake with 25-y cardiovascular (CVD) mortality in elderly Dutch men were investigated. Data from the Zutphen Elderly Study, a prospective cohort study of 774 men aged 65-84 y in 1985, were used. Epicatechin intake was estimated 4 times in 15 y. Mean intake of epicatechin was 15.2 ± 7.7 mg/d, and the major dietary sources were tea (51%), apples (28%), and cocoa (7%). During 25 y of follow-up, 329 men died from CVD, 148 died from coronary heart disease (CHD), and 72 men died from stroke. Risk of CHD mortality was 38% lower in men in the top tertile of epicatechin intake than in men in the bottom tertile of epicatechin intake (HR: 0.62; 95% CI: 0.39, 0.98). Epicatechin intake was also significantly associated with 46% lower risk of CVD mortality in men with prevalent CVD (HR: 0.54; 95% CI: 0.31, 0.96) but not in men who were free of CVD. Using data from the Nurses' Health Study and the Health Professionals Follow-Up Study , this study examined whether dietary consumption of phosphatidylcholine, which is mainly derived from eggs, red meat, and fish, is related to all-cause and cardiovascular disease (CVD) mortality in 80,978 women and 39,434 men who were free of cancer and CVD at baseline. The study also tested if such an association was modified by diabetes status. 17,829 all-cause and 4359 CVD deaths were documented during follow-up. After multivariate adjustment for potential confounders, including demographic factors, disease status, lifestyle, and dietary intakes, higher phosphatidylcholine intakes were associated with an increased risk of all-cause and CVD mortality. HRs (95% CIs) comparing the top and bottom quintiles of phosphatidylcholine intake were 1.11 (1.06, 1.17; P-trend across quintiles < 0.0001) for all-cause mortality and 1.26 (1.15, 1.39; P-trend < 0.0001) for CVD mortality in the combined data of both cohorts. The associations of phosphatidylcholine with all-cause and CVD mortality were stronger in diabetic than in nondiabetic participants (P-interaction = 0.0002 and 0.001, respectively). Vegetarian diets have been associated with a lower incidence of several chronic diseases. The benefits of plant-based diets are related mainly to the improvement of metabolic parameters that can indicate risk for such diseases. Some metabolic factors, such as oxidative balance, lipid profile, and glucose homeostasis, can be improved directly by diet, but paradoxically, some characteristics of vegetarian diets may promote a negative scenario that increases the risk of certain chronic diseases. Additionally, many benefits of a vegetarian diet are mediated by the gut microbiota, members of which not only have taxonomic and functional differences but also produce diverse, specific metabolites that vary according to whether the host consumes an omnivorous or a vegetarian diet. Significance: The paper reviews the current evidence from studies investigating the intake of cheese and cardiovascular disease (CVD) risk or CVD risk markers in the form of cholesterol concentrations.
Dietary

Vegetarian Diets and Gut
The purpose of this review is to give an overview of the existing literature regarding the effect of cheese intake and risk of cardiovascular disease (CVD). Studies included four human intervention studies, nine prospective studies, one prospective case-cohort study, one prospective nested case-control study, five case-control studies, five cross-sectional studies and three correlation studies. The possible mechanisms that may be of importance include calcium, protein, fermentation and the fatty acid composition of cheese. Results from four prospective studies reported no association between cheese intake and CVD risk, whereas one reported an increased risk, two reported a decreased risk and one reported no association in men but a decreased risk in women. In addition, results from four intervention studies indicated no harmful effect on cholesterol concentrations when comparing fat intake from cheese with fat from butter. Significance: Total whole-grain wheat and rye intake was not associated with a lower risk of type 2 diabetes (T2D) in those with high whole-grain intake; however, the proportion of whole-grain rye to whole-grain wheat intake, indicated by the plasma C17:0-to-C21:0 ratio, was inversely associated with T2D.
This nested case-control study examined the association between plasma total alkylresorcinols and the alkylresorcinol C17:0-to-C21:0 ratio, biomarkers of wholegrain wheat and rye intake and relative whole-grain rye over whole-grain wheat intake, respectively, and the risk of type 2 diabetes (T2D) among 931 case-control pairs of Scandinavian men and women. ORs for T2D were calculated for plasma total alkylresorcinol concentration or C17:0-to-C21:0 ratio in quartiles with the use of conditional logistic regression that was adjusted for potential confounders. The plasma total alkylresorcinol concentration was not associated with T2D risk (OR: 1.34; 95% CI: 0.95, 1.88) for the highest compared with the lowest quartiles in multivariable adjusted models. However, the C17:0-to-C21:0 ratio was associated with a lower diabetes risk (OR: 0.54; 95% CI: 0.37, 0.78). This narrative review examines the efficacy of chromium supplements for improving glycemic control as measured by decreases in fasting plasma glucose (FPG) or hemoglobin A1c (HbA1c). Using systematic search criteria, 20 randomized controlled trials of chromium supplementation in type 2 diabetes mellitus (T2DM) patients were identified. Clinically meaningful treatment goals were defined as an FPG of ≤7.2 mmol/dL, a decline in HbA1c to ≤7%, or a decrease of ≥0.5% in HbA1c. In only a few randomized controlled trials did FPG (5 of 20), HbA1c (3 of 14), or both (1 of 14) reach the treatment goals with chromium supplementation. HbA1c declined by ≥0.5% in 5 of 14 studies. Future meta-analyses should include only high-quality studies with similar forms of chromium and comparable inclusion/exclusion criteria to provide scientifically sound recommendations for clinicians. This randomized, controlled, crossover study determined whether acute administration of increasing doses of a common quercetin glycoside (quercetin-3-O-glucoside) improves endothelial function and reduces blood pressure (BP) in a dose-dependent manner. It also explored whether any effects were correlated with changes in plasma nitric oxide (NO) production. Subjects included 15 healthy volunteers who each completed 5 visits with a minimum washout period of 1 wk between testing days. Subjects received each of the following 5 interventions in a random order: 1) 0, 2) 50, 3) 100, 4) 200, or 5) 400 mg quercetin-3-O-glucoside. Although a significant correlation was observed between the dose of quercetin-3-O-glucoside and plasma concentrations of total quercetin (R 2 = 0.52, P < 0.001) and isorhamnetin (R 2 = 0.12, P = 0.005), no improvements in endothelial function or BP and no changes in NO production after any dose were found. Ono-Moore, R.G. Snodgrass, S. Huang, S. Singh, T.L. Freytag, D.J. Burnett, et al. Journal of Nutrition, Vol. 146, No. 7; pp. 1411 -1419 Link to full text: Click here Significance: Plasma free-fatty acid concentration may be an important determinant affecting inflammatory cytokine production in blood.
Chromium Supplements for Glycemic Control in
Blood Pressure
This study determined whether plasma free fatty acids (FFAs), after a moderately high-fat (MHF, 40% kcal from fat) breakfast, modulate the inflammatory status of postprandial blood, and whether blueberry intake suppresses FFA-induced inflammatory responses in 23 healthy volunteers. Subjects with mean ± SEM age (30 ± 3 y) and BMI (21.9 ± 0.4 kg/m 2 ) consumed a MHF breakfast with either a placebo powder or 2 or 4 servings of blueberry powder in a randomized crossover design. The median concentrations of FFAs and cytokines [tumor necrosis factor-α, interleukin (IL)-6 and IL-8] in postprandial plasma (3.5 h) decreased compared with fasting plasma regardless of the blueberry intake (P < 0.001 for FFAs and P < 0.05 for cytokines). However, concentrations of FFAs and cytokines including IL-1β increased in lipoprotein lipase (LPL)-treated whole blood compared with untreated blood samples from participants who consumed the placebo powder. Blueberry intake suppressed IL-1β and IL-6 production in LPL-treated postprandial blood compared with the placebo control when fasting changes were used as a covariate.
Lipids
The Increasing Use of Interesterified Lipids in the Food Supply and Their Effects on Health Parameters R.P. Mensink, T.A. Sanders, D.J. Baer, K.C. Hayes, P.N. Howles, A. Marangoni Advances in Nutrition, Vol. 7, No. 4; Link to full text: Click here
Significance: This paper reports on the workshop sponsored by the Technical Committee on Dietary Lipids of ILSI North America that addressed the health effects of interesterified fats, identified research needs, and outlined considerations for the design of future studies.
A variety of modified fats that provide different functionalities are used in processed foods to optimize product characteristics and nutrient composition. Partial hydrogenation results in the formation of trans FAs (TFAs) and was one of the most widely used modification processes of fats and oils. However, the negative effects of commercially produced TFAs on serum lipoproteins and risk for cardiovascular disease resulted in the Institute of Medicine and the 2010 US Dietary Guidelines for Americans both recommending that TFA intake be as low as possible. After its tentative 2013 determination that use of partially hydrogenated oils is not generally regarded as safe, the FDA released its final determination of
